Correlation Between Intellia Therapeutics and Verve Therapeutics
Can any of the company-specific risk be diversified away by investing in both Intellia Therapeutics and Verve Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Intellia Therapeutics and Verve Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Intellia Therapeutics and Verve Therapeutics, you can compare the effects of market volatilities on Intellia Therapeutics and Verve Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Intellia Therapeutics with a short position of Verve Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Intellia Therapeutics and Verve Therapeutics.
Diversification Opportunities for Intellia Therapeutics and Verve Therapeutics
0.02 | Correlation Coefficient |
Significant diversification
The 3 months correlation between Intellia and Verve is 0.02. Overlapping area represents the amount of risk that can be diversified away by holding Intellia Therapeutics and Verve Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Verve Therapeutics and Intellia Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Intellia Therapeutics are associated (or correlated) with Verve Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Verve Therapeutics has no effect on the direction of Intellia Therapeutics i.e., Intellia Therapeutics and Verve Therapeutics go up and down completely randomly.
Pair Corralation between Intellia Therapeutics and Verve Therapeutics
Given the investment horizon of 90 days Intellia Therapeutics is expected to generate 0.91 times more return on investment than Verve Therapeutics. However, Intellia Therapeutics is 1.1 times less risky than Verve Therapeutics. It trades about -0.12 of its potential returns per unit of risk. Verve Therapeutics is currently generating about -0.17 per unit of risk. If you would invest 1,634 in Intellia Therapeutics on August 27, 2024 and sell it today you would lose (204.00) from holding Intellia Therapeutics or give up 12.48% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Intellia Therapeutics vs. Verve Therapeutics
Performance |
| Timeline |
| Intellia Therapeutics |
| Verve Therapeutics |
Intellia Therapeutics and Verve Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Intellia Therapeutics and Verve Therapeutics
The main advantage of trading using opposite Intellia Therapeutics and Verve Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Intellia Therapeutics position performs unexpectedly, Verve Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Verve Therapeutics will offset losses from the drop in Verve Therapeutics' long position.| Intellia Therapeutics vs. Editas Medicine | Intellia Therapeutics vs. Caribou Biosciences | Intellia Therapeutics vs. Crispr Therapeutics AG | Intellia Therapeutics vs. Verve Therapeutics |
| Verve Therapeutics vs. Adaptive Biotechnologies Corp | Verve Therapeutics vs. Beam Therapeutics | Verve Therapeutics vs. Caribou Biosciences | Verve Therapeutics vs. Sana Biotechnology |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Comparator module to compare the composition, asset allocations and performance of any two portfolios in your account.
Other Complementary Tools
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
| Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
| Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
| Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. |